Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer.
Beyer S, Müller L, Mitter S, Keilmann L, Meister S, Buschmann C, Kraus F, Topalov NE, Czogalla B, Trillsch F, Burges A, Mahner S, Schmoeckel E, Löb S, Corradini S, Kessler M, Jeschke U, Kolben T. Beyer S, et al. Among authors: trillsch f. J Cancer Res Clin Oncol. 2023 Jul;149(8):4293-4303. doi: 10.1007/s00432-022-04271-z. Epub 2022 Sep 7. J Cancer Res Clin Oncol. 2023. PMID: 36068443 Free PMC article.
Clinical management of primary vulvar cancer.
Woelber L, Kock L, Gieseking F, Petersen C, Trillsch F, Choschzick M, Jaenicke F, Mahner S. Woelber L, et al. Among authors: trillsch f. Eur J Cancer. 2011 Oct;47(15):2315-21. doi: 10.1016/j.ejca.2011.06.007. Epub 2011 Jul 4. Eur J Cancer. 2011. PMID: 21733674 Review.
Adjuvant therapy in node-positive vulvar cancer.
Mahner S, Trillsch F, Kock L, Rohsbach D, Petersen C, Kruell A, Harter P, Jaenicke F, Woelber L. Mahner S, et al. Among authors: trillsch f. Expert Rev Anticancer Ther. 2013 Jul;13(7):839-44. doi: 10.1586/14737140.2013.811063. Expert Rev Anticancer Ther. 2013. PMID: 23875662 Review.
The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study.
Hofstetter G, Concin N, Braicu I, Chekerov R, Sehouli J, Cadron I, Van Gorp T, Trillsch F, Mahner S, Ulmer H, Grimm C, Castillo-Tong DC, Zeillinger R, Zeimet AG, Vergote I. Hofstetter G, et al. Among authors: trillsch f. Gynecol Oncol. 2013 Oct;131(1):15-20. doi: 10.1016/j.ygyno.2013.07.086. Epub 2013 Jul 20. Gynecol Oncol. 2013. PMID: 23877013 Clinical Trial.
The prognostic significance of Jun transcription factors in ovarian cancer.
Eckhoff K, Flurschütz R, Trillsch F, Mahner S, Jänicke F, Milde-Langosch K. Eckhoff K, et al. Among authors: trillsch f. J Cancer Res Clin Oncol. 2013 Oct;139(10):1673-80. doi: 10.1007/s00432-013-1489-y. Epub 2013 Aug 13. J Cancer Res Clin Oncol. 2013. PMID: 23942796
Clinical management of epithelial ovarian cancer during pregnancy.
Grimm D, Woelber L, Trillsch F, Keller-v Amsberg G, Mahner S. Grimm D, et al. Among authors: trillsch f. Eur J Cancer. 2014 Mar;50(5):963-71. doi: 10.1016/j.ejca.2013.12.020. Epub 2014 Jan 23. Eur J Cancer. 2014. PMID: 24462638 Review.
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.
Trillsch F, Mahner S, Vettorazzi E, Woelber L, Reuss A, Baumann K, Keyver-Paik MD, Canzler U, Wollschlaeger K, Forner D, Pfisterer J, Schroeder W, Muenstedt K, Richter B, Fotopoulou C, Schmalfeldt B, Burges A, Ewald-Riegler N, de Gregorio N, Hilpert F, Fehm T, Meier W, Hillemanns P, Hanker L, Hasenburg A, Strauss HG, Hellriegel M, Wimberger P, Kommoss S, Kommoss F, Hauptmann S, du Bois A. Trillsch F, et al. Br J Cancer. 2015 Feb 17;112(4):660-6. doi: 10.1038/bjc.2014.648. Epub 2015 Jan 6. Br J Cancer. 2015. PMID: 25562434 Free PMC article. Clinical Trial.
113 results